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Abstract
Background: Phyllanthus is a traditional medicinal plant that has been used in the treatment of many diseases including
hepatitis and diabetes. The main aim of the present work was to investigate the potential cytotoxic effects of aqueous and
methanolic extracts of four Phyllanthus species (P.amarus, P.niruri, P.urinaria and P.watsonii) against skin melanoma and
prostate cancer cells.
Methodology/Principal Findings: Phyllanthus plant appears to possess cytotoxic properties with half-maximal inhibitory
concentration (IC50) values of 150–300 mg/ml for aqueous extract and 50–150 mg/ml for methanolic extract that were
determined using the MTS reduction assay. In comparison, the plant extracts did not show any significant cytotoxicity on
normal human skin (CCD-1127Sk) and prostate (RWPE-1) cells. The extracts appeared to act by causing the formation of a
clear ‘‘ladder’’ fragmentation of apoptotic DNA on agarose gel, displayed TUNEL-positive cells with an elevation of caspase-3
and -7 activities. The Lactate Dehydrogenase (LDH) level was lower than 15% in Phyllanthus treated-cancer cells. These
indicate that Phyllanthus extracts have the ability to induce apoptosis with minimal necrotic effects. Furthermore, cell cycle
analysis revealed that Phyllanthus induced a Go/G1-phase arrest on PC-3 cells and a S-phase arrest on MeWo cells and these
were accompanied by accumulation of cells in the Sub-G1 (apoptosis) phase. The cytotoxic properties may be due to the
presence of polyphenol compounds such as ellagitannins, gallotannins, flavonoids and phenolic acids found both in the
water and methanol extract of the plants.
Conclusions/Significance: Phyllanthus plant exerts its growth inhibition effect in a selective manner towards cancer cells
through the modulation of cell cycle and induction of apoptosis via caspases activation in melanoma and prostate cancer
cells. Hence, Phyllanthus may be sourced for the development of a potent apoptosis-inducing anticancer agent.
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Introduction
Cancer is a name given to group of diseases that arise from
uncontrolled growth, spread of an abnormal cell and can result in
death. It is extremely hard to treat due to several distinct classes of
tumours that exhibit different responses to treatment and not all
anticancer agents effectively give a positive response in every case
[1]. Some have been reported to exhibit toxicity to normal cells,
accompanied by undesirable effects such as vomiting, nausea and
alopecia. Thus, ineffective anticancer agents have resulted in high
death rates in cancer patients [2]. Melanoma is a type of skin
cancer that arises from melanocytes, a pigment-producing tanning
cell. Melanoma incidence and its mortality rate are high in fair-
skinned populations in all parts of the world, including Australia,
USA and UK [3–4]. Prostate cancer is the second leading cause of
cancer deaths after lung cancer worldwide [3]. Currently, there
are no effective treatments for both melanoma and prostate
cancer, and as such intense research is required to obtain new
anticancer agents for these cancers.
The high mortality in cancer patients has led many researchers
to source for potential natural-product based therapeutic com-
pounds [2]. Herbal plants and plant-derived medicines have been
used as the source of potential anticancer agents in traditional
cultures all over the world and are becoming increasingly popular
in modern society [5]. The potential natural product-derived
anticancer agents are known to possess various bioactive
compounds such as roscovitine from red radish and flavopiridol
from Amoora rohituka, a tropical tree that has shown tremendous
effects in the treatment of cancers [6–8].
The plant of the genus Phyllanthus belongs to the family
Euphorbiaceae and has been reported to have pharmacological
effects such as antiviral activity against Hepatitis B and related
hepatitis viruses [9–12], anti-bacterial activity [13,14], anti-
hepatotoxic or liver-protecting activity [15–19] as well as anti-
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has also exhibited hypoglycaemia properties [21,22]. Although the
plant genus Phyllanthus has been shown to be beneficial for human
health, but its effectiveness against cancer has not been fully
elucidated.
One of the challenges in cancer treatment is that cancer
possesses the ability to evade apoptosis (or programme cell death)
which leads to its ineffectiveness as a cytotoxic drug to kill cancer
cells. The apoptotic process is an important cell death mechanism
in response to cytotoxic treatment and its induction is a highly
desirable mode for an anticancer agent [23]. Cell cycle is a process
that acts as a key to control growth and proliferation of a cell. The
disruption of the cell cycle process will cause an imbalance
between cell proliferation and cell death (apoptosis), subsequently
leading to cancer development. Thus, cell cycle could serve as
target for anticancer agent to halt uncontrolled proliferation of
cancer cells and to initiate them to undergo apoptosis [24]. The
cytotoxic effects of Phyllanthus extracts (aqueous and methanol) on
growth inhibition against skin melanoma and prostate cancer cells
in their cell cycle could partially explain their mode of activity.
The objective of the present study was to determine the cytotoxic
effect of Phyllanthus extracts on the proliferation of skin and
prostate cancer cells and also to investigate the relationship of
these antiproliferative effects with probable apoptosis and cell cycle
modulation.
Results
Cytotoxic activity of aqueous and methanolic extracts of
Phyllanthus species
In this study, we investigated the cytotoxic effects of crude
aqueous and methanolic extracts of four different Phyllanthus
species, P.amarus, P.niruri, P,urinaria, and P.watsonii, on two human
cancers (MeWo and PC-3) as well as normal (CCD-1127Sk and
RWPE-1) cell lines. The cytotoxic properties of the Phyllanthus
extracts were determined using the MTS [3-(4,5-dimethylthiazol-
2-yl]-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazo-
liuminner salt) reduction assay. The principle behind this assay is
based on the reduction ability of a soluble tetrazolium salt, by
mitochondrial dehydrogenase enzyme of viable cells, into a
coloured soluble formazan product that can be measured
spectrophotometrically. The half-maximal inhibitory concentra-
tion (IC50) value was determined from the constructed dose-
response curve and set as a parameter for cytotoxicity.
Table 1 shows the comparison of IC50 values for both crude
aqueous and methanolic extracts of the four Phyllanthus species on
both human cancer (MeWo and PC-3) and normal (CCD-1127Sk
and RWPE-1) cell lines. Result reveals the presence of cytotoxic
effects of Phyllanthus species on both skin melanoma and prostate
cancer cells, where the respective IC50 values of Phyllanthus extracts
were determined. In comparison, the plant did not show any
significant cytotoxic effects on normal human cells, while, the
standard anticancer drugs (59Fluorouracil and Doxorubicin)
showed stronger cytotoxic effect than the Phyllanthus extracts, but
exhibits toxicity on normal cells (Table 1). Among the four
Phyllanthus plant species, P.urinaria showed strongest cytotoxic
effect, followed by P.watsonii, P.niruri and P.amarus. In addition, the
IC50 values of the methanol extracts of Phyllanthus species were
noticeably lower than the aqueous extracts on both cancer cells
indicating that the methanol extract is more cytotoxic than
aqueous extract.
Identification of polyphenols in Phyllanthus species
Methanol and water-soluble extracts obtained from various
species of Phyllanthus were subjected to analysis by HPLC (High-
Performance Liquid Chromatography) coupled with photodiode
array (PDA) and MS-MS detection allowing the identification of
polyphenol compounds (Table 2). Twelve main compounds were
identified on the basis of their retention times, UV spectra, and
parent mass spectra and secondary fragmentation patterns. The
compounds detected were gallic acid, galloylglucopyronside,
digalloylglucopyronside, trigalloylglucopyronside, tetragalloylglu-
copyronoside, corilagen, geraniin, rutin, quercetin glucoside,
quercetin diglucoside,quercetin rhamnoside, and caffeolquinic
acid.
DNA fragmentation
One of the biochemical hallmarks in the apoptotic process is the
formation of nuclear DNA fragmentation, which shows the
presence of typical ladder DNA fragments of 180 – 200 base
pairs and multiples thereof on an agarose gel. In contrast, random
cleavage of DNA in necrotic cells will produce a diffuse smear
upon electrophoresis of DNA. Hence, DNA gel electrophoresis
method was used to determine the possible mode of cell death
Table 1. IC50 values of Phyllanthus extracts and standard anticancer drugs on both human cancer and normal cell lines.
IC50± SEM (mg/ml)
Skin cells Prostate cells
Phyllanthus species Extracts Cancer (MeWo) Normal (CCD-1127Sk) Cancer (PC-3) Normal (RWPE-1)
P.amarus Aqueous 193.361.3 .500 178.362.8 .500
Methanol 133.362.9 .500 84.361.1 .500
P.niruri Aqueous 260.062.4 .500 155.061.2 .500
Methanol 153.362.6 .500 117.762.1 .500
P.urinaria Aqueous 193.361.1 .500 155.762.1 .500
Methanol 56.2163.2 .500 54.262.1 .500
P.watsonii Aqueous 160.063.2 .500 156.762.4 .500
Methanol 100.762.0 .500 100.561.2 .500
59-Fluorouracil 2.360.5 0.860.5 1.0 60.3 1.060.5
Doxorubicin 2.560.5 1.060.2 2.5 60.5 1.060.1
doi:10.1371/journal.pone.0012644.t001
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DNA fragments produced by treatment of MeWo cells with
Phyllanthus extracts and a similar pattern was seen with the
standard drug (59Fluorouracil) as positive control. No ladder
formation was observed in untreated cells. These phenomenons
were also observed in PC-3 cell line for both extracts as shown in
Figure 1B. Thus, this indicates that both extracts of Phyllanthus
were capable of inducing apoptosis or programmed cell death on
Table 2. Polyphenol compounds detected in Phyllanthus species.
Compound
Retention time in water extract
(w) or methanol extract(m) [M-H] m/z MS-MS fragmentation Phyllanthus species
Gallic acid 3.8 (w) 169 125,169 P.amarus, P.niruri, P.urinaria, P.watsonii
Galloylglucopyronoside 2.8 (w) 331 125,169,211,271 P.amarus, P.niruri, P.urinaria, P.watsonii
Digalloylglucopyronoside 15.0 (w) 483 125,169,211, 271, 313 P.amarus, P.niruri, P.watsonii
Trigalloylglucopyronoside 23 (w), 13 (m) 635 125,169,211, 271, 313,465 P.urinaria
Tetragalloylglucopyronoside 15 (m) 787 169,211, 313, 465 P.urinaria
Corilagen 18 (w) 633 301, 125, 169 P.amarus, P.niruri, P.urinaria, P.watsonii
Geraniin 22 (w), 12 (m) 951 301, 125, 169, 463 P.amarus, P.niruri, P.urinaria, P.watsonii
Rutin 26 (w) 609 301, 179,151 P.amarus, P.niruri, P.urinaria, P.watsonii
Quercetin glucoside 27 (w) 463 301, 179,151 P.amarus, P.niruri, P.urinaria, P.watsonii
Quercetin diglucoside 9 (m) 625 463, 301 P.niruri
Quercetin rhamnoside 30 (w) 447 301, 151 P.urinaria, P.watsonii
Caffeolquinic acid 23 (w) 353 191 P.amarus, P.niruri, P.urinaria, P.watsonii
doi:10.1371/journal.pone.0012644.t002
Figure 1. Apoptotic DNA fragmentation was observable in Phyllanthus extracts-treated MeWo and PC-3 cells. Lane 1 -4: aqueous and
Lane 6 – 9: methanol extracts for P.amarus, P.niruri, P.urinaria and P.watsonii, in the order. Lane 5 and 10: 1 kb DNA marker, Lane 11: standard drug,
where A)5 9Fluorouracil for MeWo and B) Doxorubicin for PC-3 cells. Lane 12: untreated cells.
doi:10.1371/journal.pone.0012644.g001
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TUNEL assay and Apoptotic Index
TUNEL (terminal deoxynucleotidyl transferase dUTP nick end
labeling) assay is a technique to allow detection of apoptotic cells
by labelling the free end of apoptotic DNA with a marker which
can be visualized under light microscope. As shown in Figure 2,
apoptotic cells were observed as brown-coloured cells in Phyllanthus
extracts-treated MeWo (Figure 2A, arrowhead) and PC-3
(Figure 2B, arrowhead) cancer cells, their appearance were similar
to apoptotic cells that were present in the positive controls,
apoptotic-inducer anticancer drug (59Fluorouracil and Doxorubi-
cin), while viable cells were stained blue. This further confirms that
Phyllanthus extracts were capable of inducing apoptosis on skin
melanoma and prostate cancer cells. The populations of cell death
can be calculated and expressed in a mathematical way, known as
apoptotic index. From Figure 2C, the cell death percentage
(apoptotic index) of treated-MeWo and PC-3 cells were markedly
increased up to 50% compared to the control group at 72 hours of
treatment with Phyllanthus extracts. In addition, the percentage of
Phyllanthus extracts induced apoptotic cells was close to the
anticancer drugs (59Fluorouracil and Doxorubicin) with only 8%
difference.
Phyllanthus extracts-induced caspase-3/7 activations
An activation of caspases (aspartate specific cysteine protease) is
one of the biochemical changes during apoptosis. The levels of
caspase-3/7 induced by Phyllanthus treatment were markedly
increased (3–4 folds) as compared to the untreated group
(Figure 3) for both extracts of Phyllanthus. The level of caspase-3/
7 of standard drugs, 59Fluorouracil and Doxorubicin on MeWO
and PC-3 cells, respectively, were 6-folds increase as compared to
that of the control group and 0.5-fold higher than Phyllanthus
extracts after 72 hours of treatment. These indicates that apoptosis
induced by Phyllanthus extracts was mediated via caspases
activation.
Phyllanthus extracts-induced minimal necrotic effect
Necrosis is another form of cell death that will provoke
inflammatory response of surrounding cells through the leakage
of intracellular contents. As shown in Figure 4, the percentage of
LDH levels produced as a result of treatment with both extracts of
Phyllanthus species was less than 10% for MeWo cells and less than
15% for PC-3 cells, as compared to that of the control groups after
72 hours of treatment. The necrotic effect of methanol extracts
was more pronounced, where it was observed to be 4% higher
than the aqueous extract of Phyllanthus species. This suggests that
the Phyllanthus species possesses minimal necrotic effects and skin
Figure 2. Induction of Apoptosis. TUNEL analysis of MeWo and PC-3 cancer cells after being treated with Phyllanthus extracts at 1006
magnification. TUNEL-positive (apoptotic) cells were observable as brown stained cells (red arrow) in Phyllanthus extracts-treated A) MeWo and B)
PC-3 cells and normal viable cells stain as blue colour. C) The graph shows the percentage of apoptotic index (%) of untreated and treated
(Phyllanthus extracts and anticancer drugs) MeWo and PC-3 cancer cells from TUNEL analysis.
doi:10.1371/journal.pone.0012644.g002
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cancer cells. In contrast, the LDH level induced by the positive
control (59Fluorouracil and Doxorubicin) was 25% higher than the
untreated cells and 18% in variation with the Phyllanthus–treated
cells at 72 hours of treatment.
Phyllanthus extracts induce cell cycle arrest followed by
apoptosis
To determine the phase of cell cycle that is inhibited by
Phyllanthus plant extracts, both MeWo and PC-3 cells were treated
Figure 3. Phyllanthus extracts induce caspase-3 and -7 activation. The graph shows the levels of caspase-3 and -7 in treated and untreated
groups of MeWo and PC-3 cells. Bars show the mean ± SE
doi:10.1371/journal.pone.0012644.g003
Figure 4. Phyllanthus extracts induce minimal necrotic effect. The graph shows the percentage of LDH levels in Phyllanthus-extracts treated
MeWo and PC-3 cancer cells were higher than the untreated group after 72 hours of treatment. Bars show the mean percentage ± SE
doi:10.1371/journal.pone.0012644.g004
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then analysed by flow cytometry. The kinetics of the cell cycle
distribution of treated and untreated groups of MeWo and PC-3
cells were shown in Figure 5 and 6, respectively. Changes in the
distribution of treated cells in different phases of cell cycle were
observable by 24 hours after being treated with Phyllanthus extracts
for the both cancer cell lines.
As seen in the Figure 5, Phyllanthus extracts exhibited growth
arrest at the S-phase in MeWo cells from 24 hours and remained
evident after 72 hours of treatment and this was accompanied by
an accumulation of cells in the Sub-G1 (apoptosis cells) phase for
both aqueous and methanolic extracts. The percentage of
apoptotic cells had increased in a time-dependent manner from
1.8% at 24 hours to 6.1% at 72 hours as compared to the control
groups (Figure 5A). Meanwhile, the percentage of cells at the S-
phase of treated MeWo cells was elevated to 15% above the
controls at 72 hours of treatment (Figure 5C). Furthermore, the
percentage of cells at Go/G1 and G2/M phases decreased with
time upon treatment with Phyllanthus extracts due to the fact that
treated cells have been arrested at S-phase and subsequently
accumulated at Sub-G1 (apoptosis) phase (Figure 5B and 5D).
However, the potency of Phyllanthus extracts to induce S-phase
arrest was not as the strong as standard drug (59Fluorouracil), with
a 22.1% difference at 72 hours post treatment.
For PC-3 cells, Phyllanthus exhibited growth arrest at the Go/G1
phase at 72 hours post treatment with an accumulation of
apoptotic cells in the Sub-G1 phase for both aqueous and
methanolic extracts. The percentage of apoptotic cells increased
from 3.4% at 24 hours up to 7.4% at 72 hours over the untreated
groups (Figure 6A). The percentage of treated PC-3 cells at Go/
G1-phase was 13.7% at 24 hours and this increased to 18.8% at
72 hours above the untreated groups (Figure 6B). However, the
percentage of treated-PC-3 cells at the S and G2/M phases
decreased with time of treatment (Figure 6C and 6D) due to the
fact that treated PC-3 cells were arrested at Go/G1 phase and
subsequently accumulated at Sub-G1 phases. While doxorubicin
showed a G2/M phase arrest on PC-3 cells at 24 hours and
remained evident after 72 hours of treatment.
Discussion
Man has used plants extensively for treating various kinds of
diseases since ancient times [7]. Herbal plants and plant-derived
medicines have been widely used in traditional cultures all over the
world and have gained popularity in modern society as natural
alternatives to produce new potential therapeutic compounds for
combating diseases [5]. Sixty percent of today’s available
anticancer drugs originated from natural products, and their
derivatives (including antibiotics). This has resulted in greater
confidence in natural products as important sources for the
development of effective anticancer agents [7].
In the present study, both aqueous and methanol extracts of
four plant species of Phyllanthus displayed cytotoxic effects on
human skin melanoma (MeWo) and prostate (PC-3) cell lines. The
variations in the IC50 values of Phyllanthus extracts against
melanoma and prostate cancer cells might be due to the differing
levels of bioactive compounds present in each Phyllanthus species
such as quercetin, gallic acid, and caffeolquinic acid that have
been proven to possess anticarcinogenic effects [16,25–27]. In
addition, the data obtained suggest that the methanolic extract of
Phyllanthus seemed to have more pronounced cytotoxic effect than
aqueous extract, indicating the methanol-soluble bioactive com-
pounds contained in Phyllanthus are probably more potent than the
aqueous-soluble bioactive compounds in killing cancer cells.
Among the four Phyllanthus species used, P. urinaria showed the
strongest cytotoxic effect. This could be associated to its exclusive
content of trigalloylglucopyronoside and tetragalloylglucopyrono-
sid. Interestingly, Phyllanthus extracts did not cause any significant
changes on the cell viability of both normal human skin (CCD-
1127Sk) and prostate (RWPE-1) cell lines. These findings correlate
with studies carried out by Huang et al. in which Phyllanthus plants
displayed selective killing against cancer cells [28]. This selective
cytotoxic effect is an important criterion because the currently
available drugs target normal cells as well and leads to side effects.
The life and death of a cell is controlled by the cell cycle, which is
tightly regulated by cyclin, cyclin-dependent kinases (CDK), CDK
inhibitors (CDKI) and other tumour suppressor genes. Thus,
deregulation of cell cycle will lead to abnormal proliferation of
DNA-damaged cells and evasiveness of apoptosis [29]. Phyllanthus
extracts disrupted the cell cycle of MeWo cells at S-phase, thereby
implying that they might have interfered with DNA synthesis,
halting the progression of cell cycle at S-phase and leading to
apoptosis. The S-phase arrest by Phyllanthus extracts on MeWo cell
could be due to: (1) inhibition of cdc25 enzymes [16,30–32], or (2)
inhibition of DNA Topoisomerase II which leads to activation of
caspases [16,33]. Thus, high levels of caspase-3 and -7 activities
were detected after 72 hours post treatment of Phyllanthus extracts.
However, S-phase arrest exhibited by Phyllanthus extracts were not
as pronounced as 59Fluorouracil, which is an S-phase sensitive skin
anticancer drug, indicating that Phyllanthus extracts probably kill
melanoma cells in other ways besides disrupting the cell cycle, such
as alterations in melanoma’s cell signalling pathways including FAS
pathway [34]. Further investigations will address the mode of
actions of Phyllanthus extracts on melanoma cells.
Phyllanthus extracts exerted their growth arrest on treated-PC-3
cells by accumulating the cells at Go/G1-phase, implying that
Phyllanthus extracts may interfere with protein synthesis of PC-3
cells thus halting their progression from G1 to S phase during their
cell cycle and subsequently initiating apoptosis. This could be due
to the inhibitory effects on MDM2 protein, which reduces cell
proliferation and induces apoptosis by the elevation of p21, Bax
and pRb levels as well as reduction of hyperphosphorylated Rb
and E2F1 [35]. Phyllanthus-induced apoptosis in PC-3 cells might
be associated with elevations of Bax and Fas receptor/ligand gene
expression as proposed by Huang et al. [25]. The elevations of Bax
protein is associated with the involvement of mitochondrial
(intrinsic) pathway in apoptosis which involves the reduction of
mitochondrial membrane potential, cytochrome C releases and
subsequently leading to caspases activation [36]. High levels of
caspase-3 and -7 activities were detected in cells treated with
Phyllanthus extracts. The Go/G1-phase arrest on PC-3 by
Phyllanthus extracts might be associated to its high content of
polyphenol compounds. The 12 polyphenols identified in
Phyllanthus, are classified into four main groups, namely,
ellagitannins, gallotannins, flavonoids and phenolic acids with
ellagitannins being the most abundant group of compound.
Ellagitannins are also abundantly found in pomegranate and have
been studied quite thoroughly for its varied therapeutic effects
including its cancer suppressing properties [37]. Geraniin, the
main ellagitannin found in all the Phyllanthus species, have been
shown to contribute to growth arrests on other cancers including
colon cancer [38,39]. However, the standard drug for prostate
cancer, Doxorubicin, disrupted the growth of cancer cells by
arresting them at G2/M phase and eventually initiating apoptosis
by a variety of mechanisms such as inhibition on topoisomerase
enzymes as seen in other studies [40,41].
The activation of caspase-3 and -7 activities in treated cancer
cells during apoptosis results in: (1) inactivation of enzyme poly
Phyllanthus spp & Cancer Cells
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activated DNase (CAD), subsequently causing DNA fragmenta-
tion, which is one of characteristics of apoptosis [42,43]. Thus,
elevation of these caspases after Phyllanthus treatments allows the
appearance of apoptotic DNA fragments on agarose gel which was
further confirmed with the presence of TUNEL-positive cells.
Hence, the cytotoxic effects of Phyllanthus extracts on human skin
(MeWo) and prostate (PC-3) cancer cell lines was mediated via an
apoptotic mechanism with activation of caspase-3 and -7 and this
could be due to the presence of gallic acid found in Phyllanthus
extracts. Gallic acid has previously been proven to induce
apoptosis via caspase-3 activation [44].
In natural product-based drug discovery and development,
necrosis may occur along with apoptosis. This has been shown in
many anticancer drugs such as cladribine, cisplatin, doxorubicin
and 59fluorouracil, which possess both apoptotic and necrotic
effects [45,46]. The LDH are a group of enzymes that are present
in our body and their abnormally high level indicates health
problems. In cells, LDH are mainly produced by the mitochondria
and play an important role in oxidation of lactate while reducing
pyruvate [47]. In necrotic cell death, plasma membrane integrity is
lost and this leads to the leakage of cytoplasmic contents into the
extracellular environment causing an inflammatory reaction [23].
Measurements of LDH enzyme as an indicator of necrosis,
demonstrated that Phyllanthus besides having apoptotic activity,
also possess minimal capacity of inducing necrotic cell death on
both MeWo and PC-3 cells. Taken together, the results indicate
that Phyllanthus plant possesses dual-capability of cell death,
perhaps due to the crude nature of the Phyllanthus extracts, where
all potential bioactive compounds are mixed together and may act
individually or in synergism, thus contributing to this dual-
capability of cell death’ effects.
These bioactive compounds are believed to possess cytotoxicity
towards cancer cells through its ability to disrupt the cell growth of
cancer and initiate them to undergo apoptotic cell death. Although
the detailed or underlying mechanisms of selectivity of Phyllanthus
plant against skin and prostate cancer cells is still unclear, our
findings have revealed that Phyllanthus plant exerts its growth
inhibition towards cancer cells through modulation of cell cycle
and induction of apoptosis via caspases activation. Further
purifications of Phyllanthus extracts and investigations of the
apoptosis pathway are needed to reveal the exact mode of action
of Phyllanthus plant for its anti-cancer properties.
Materials and Methods
Plant Extracts and Standard Drugs
Aqueous and methanolic extracts of four Phyllanthus species
(P.amarus, P.niruri, P.urinaria, and P.watsonii) were provided by Dr.
Indu Bala, Biotechnology Centre, MARDI. Freshly harvested
plant samples were washed, dried in room temperature and then
freeze dried. For the aqueous extract, dried plant sample were
soaked with ultra pure water, while absolute methanol was used
for the methanolic extract preparation. The samples were then
homogenized with extraction buffer and the supernatant collected
after three rounds of extraction. Doxorubicin and 59Fluorouracil
were the standard drugs used as positive controls in this study.
Both tested samples; plant extracts and standard drugs were stored
at 220uC.
High performance liquid chromatography coupled with
electronspray ionization (ESI) and mass spectrometry (LC-
MS- MS) analysis
For water extracted samples, 2 ml of supernatant was dried in a
vacuum concentrator (Concentrator 5301 eppendorf, Germany)
and re-dissolved into 20 mg/ml with 30% methanol before being
subjected for LC-MS-MS analysis. For those samples extracted
with methanol, total supernatant was evaporated using rotary
evaporator (Rotavapor RII, BUCHI, Switzerland) and re-
dissolved again with 20% methanol. Samples then were separated
with solid phase extraction (SPE) column (LiChrolut RP-18
1000 mg/6 ml, Merck Germany) with mobile phase of 60%
methanol and 70% methanol. All elutes were concentrated to
0.5 ml, then diluted 8 times with 40% methanol before being
subjected for LC-MS-MS analysis.
Samples were separated using HPLC system comprising of a
HPLC binary pump, an autosampler injector compartment and
diode array detector (DAD) (1200 series, Agilent Technologies,
Germany). Separations were carried out using a reverse phase C-
18, 150 mm 64.6 mm i.d, 5 mm particle size Thermo Hypersil
GOLD column (Thermo Scientific, UK). Separation was
developed using a mobile phase of 0.1% formic acid in water
(solvent A) and 0.1% formic acid in acetonitrile (solvent B) with a
gradient setting of solvent B: 5% (5 min), 5–90% (60 min), 5%
(4 min) at flow rate of 1 ml/min. The injection volume was set at
20 ml and the detections were both at 280 nm and 360 nm. For
mass spectrometry analysis, 3200 QTrap LC/MS/MS system
(Appiled Bioscience – MDS Sciex) was used with the iron source
and voltage was maintained at 500uC and 24.5 kV for negative
ionization, respectively. Nitrogen generator was set to be operated
at 60 psi curtain gas flow, 90 psi source gas flow and 60 psi exhaust
gas flow. Two types of scanning modes were chosen: enhance mass
spectrometer (EMS) and enhance ion product (EPI) for a full scan
mass spectra ranging from m/z 100–1200.
Cell culture
Skin melanoma MeWo (HTB-65) cell, prostate cancer PC-3
(CRL-1435) cells, normal human skin CCD-1127Sk (CRL-2565)
and prostate RWPE-1 (CRL-11609) cell lines were purchased
from American Type Culture Collection (ATCC). The four cell
lines were cultured with different media, EMEM (Eagle’s
minimum essential medium) for MeWo cells, RPMI-1640 (Roswell
Park Memorial Institute) for PC-3 cells, and keratinocyte growth
medium, CC-4455 (Lonza, USA) for RWPE-1 cells and DMEM
(Dulbecco’s modified Eagle Medium) for CCD-1127Sk cells.
Growth media was supplemented with 10% heat-inactivated foetal
bovine serum (FBS, Gibco). Cells were maintained in humidified
air with 5% CO2 at 37uC. Cells were harvested using 0.25%
trypsin (Hyclone) when they reach 70–80% confluency in culture
flasks. Cells undergoing exponential growth were used throughout
the experiments.
Cytotoxicity screening
Cells were seeded at optimal cell density into sterile 96-well
plates and incubated overnight for attachment. The stock solution
of Phyllanthus extracts was serially diluted and added to the cells to
reach a final concentration at a range of 15.63–500 mg/mL and
finally incubated for 72 hours. Anticancer drugs, Doxorubicin
Figure 5. The kinetics of cell cycle distribution of Phyllanthus extracts treated MeWo cells. The percentage of Phyllanthus extracts-treated
cells at A) Sub-G1, B) Go/G1, C) S, and D) G2/M phases of MeWo cells at different time intervals (24, 48, 60 and 72 hours) of treatment. Bars show
the mean percentage ± SE
doi:10.1371/journal.pone.0012644.g005
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controls for PC-3 and MeWo cells, respectively. After 72 hours,
the cytotoxicity screening was performed using CellTiter 96H
AQueous Non-Radioactive Cell Proliferation Assay kit (Promega,
USA) according to the manufacturer’s instructions. Briefly, MTS/
PMS solution was added in equal volumes and the plate was stored
in the dark for 1 hour before determining their absorbance at
490 nm with the reference wavelength at 600 nm by using
GloMax Multi Detection System (Promega, USA). The absor-
bance value that was determined for untreated cells was based on
100% viable cells. Each measurement was performed in triplicates.
The IC50 values of Phyllanthus extracts on both the cancer cell lines
were determined and used in subsequent experiments.
Apoptosis analysis
DNA fragmentation. Phyllanthus extracts treated-cancer cells
were lysed with lysis buffer (1M Tris-HCI, 0.5M EDTA, Triton-X
and distilled water) and incubated at 4uC for 35 minutes. The DNA
sample was extracted by mixture of phenol:choloroform:isoamyl
(25:24:1) and precipitated with equal volume of ice-cold
isopropanol. Cells were then centrifuged for 30 minutes at 10,
000 rpm and pellet was resuspended with deionized water-RNase
solution (10 mg/ml RNase I). The DNA sample was incubated at
37uC for 30 minutes and electrophoresed on a 1.2% agarose gel
containing 1 mg/ml ethidium bromide (Sigma) for 1 hour at 100
volts. Finally, the apoptotic DNA fragments were visualized under
a UV transilluminator (Vilbir Lourmat) and photographed
(Olympus).
TUNEL assay and Apoptotic Index (AI)
The presence of apoptotic cells were determined using the
ApopTag Plus Peroxidase In Situ Apoptosis Detection Kit
(Chemicon International), which is based on the principle of
TUNEL. Briefly, trypsin-detached cells were fixed with 1%
paraformaldehyde in PBS (pH 7.4) and dried on a silanized glass
slide. Pre-cooled ethanol:acetic acid (2:1. v/v) was used for post-
fixation of cells on the slide for 5 minutes at 220uC. Endogenous
peroxidase was quenched by 3% H2O2 added at room temperature
for 15 minutes. The apoptotic DNA fragments were labelled with
digoxigenin antibody with TdT (terminal deoxynucleotidyl trans-
ferase)enzyme and then conjugated withanti-digoxigenin antibody.
The labelled peroxidase-apoptotic DNA fragments were then
treated with peroxidase substrate, diaminobenzidine (DAB) to
produce a permanent, localized brown-coloured stain. Methyl
green was used to counterstain the cells to further differentiate the
apoptotic cells from viable normal cells. The slide was observed
under light microscope and photographed at a magnification at
100X. The number of apoptotic cells were calculated from a total of
at least 1000 apoptotic cells at 1006magnification and presented as
an apoptotic index. Apoptotic cells were identified in TUNEL assay
by apoptosis characteristic morphological changes such as cell
shrinkage, membrane blebbing, and chromatic condensation. The
percentage of apoptotic index was presented as the mean of
experiments conducted in triplicates.
Caspase-3 and -7 detection
Caspase-3/7 activity of treated-cells was detected by Caspase-
GloH-3/7 Assay system kit (Promega, USA) after 72 hours of
treatment with Phyllanthus extracts. Briefly, an equal volume of
Caspase-GloH 3/7 reagent was added and luminescence signal was
recorded using GloMax Multi Detection System (Promega, USA)
after incubation at room temperature for 1 hour. The percentage
of caspase-3/7 of Phyllanthus extract-treated cell was determined,
where the background luminescence associated with the culture
media and assay reagent (blank reaction) was subtracted from the
experimental values of 96-well white walled plate. The percentage
activity of caspase-3/7 level was presented as the mean of
experiments conducted in triplicates.
LDH measurements
LDH enzyme was used as an indicator for necrosis and was
measured using a CytoTox-One (TM) Homogenous Membrane
Integrity kit (Promega, USA) according to the manufacturer’s
instruction. Briefly, an equal volume of CytoTox reagent was
added and incubated at room temperature for 10 minutes. Fifty
microlitres of stop solution was added and fluorescence signal was
measured at an excitation wavelength of 560 nm and an emission
wavelength of 640 nm by using GloMax Multi Detection System
(Promega, USA). The LDH levels were presented as the mean of
experiments conducted in triplicate manner.
Cell cycle analysis
Cells treated with respective IC50 value of Phyllanthus extracts
were incubated at different time intervals; 24, 48, 60 and 72 hours.
The floating and trypsin-detached cells were collected and fixed in
70% ethanol. The ethanol-fixed cells were spun down and washed
twice with ice-cold PBS. The cell pellet was stained with
propidium iodide (10 mg/ml) (Sigma) in PBS (Flowlab) containing
RNase A (100 mg/ml) and was incubated in a 37uC water bath
(Memmert) for 30 minutes in the dark before being analyzed on a
FASCalibur flow cytometer (Becton Dickinson, USA). The
percentage of cells at the different phases of the cell cycle was
quantitated using WinMDI software. The percentage of hypodip-
loid cells (Sub-G1) over total cells was calculated and expressed as
percentage of apoptotic cells.
Data analysis
Results were expressed as the mean 6 standard error (SE) of
data obtained from triplicate experiments.
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